Page 57 - Sohini Das

Pharma exports likely to touch all-time high of $27 bn in FY23 riding on EU

Better figure expected despite global headwinds; India has so far exported pharma products worth $16.57 bn during April-November this year

States to conduct mock drills next week to review Covid preparedness

Specific focus on oxygen plants, ventilators, logistics and human resources; aim is to check whether the equipment is in running condition, or needs refurbishment

As Covid-19 cases fall, Indians drag feet to get their booster shots

Less than 30,000 booster doses daily in December, vaccine coverage flat for two months

Mask up, take the jab, Covid is not over yet, Centre cautions citizens

A new and highly transmissible BF.7 strain of the Omicron variant is behind a widespread surge of Covid infections in China

Maiden Pharma cough syrup row: Gambian Parliament seeks legal action

WHO, however, said samples tested in Ghana and Switzerland were found to be contaminated

As China cases surge, India must keep an eye on raw material supplies

Epidemiologist forecasts 10% of world population will be infected in next 90-days

Maiden Pharma seeks to reopen Sonipat plant after DCGI clearance

However, the DCGI has now said the cough syrups in question were found not to be contaminated, and met with government standards

WHO stands by action of issuing alert against Maiden Pharma cough syrup

Asserts that testing done in labs in Ghana and Switzerland confirmed excess levels of contaminated syrups that are "dangerous and should not be in any medicine, ever"

Maiden Pharma's cough syrups are safe, WHO jumped the gun: DCGI

'Irreparable damage' to Indian pharma's global image, drug regulator writes to WHO

Rising cost of raw materials a challenge for drug firms: Cipla's Hamied

Companies will have to manage work to match India's National List of Essential Medicines but it will be worth the endeavour, she says

M&M to invest Rs 10,000 cr to set up plant in Pune for upcoming EV range

Auto major aims to have 30% of its sales to be from electric vehicles by 2027

As India again reports Zika virus case, focus turns to vaccine, testing

Bharat Biotech's Zikavac now in clinical trial; labs look to offer Zika virus test

Eyestem to start first trial in India to treat age-related blindness

The first nine patients that they will inject would be legally blind, as they have to prove safety first

Drug regulators, pharma firms step up action on fake and substandard drugs

Detection of spurious and substandard drugs was up by 47% from 2020 to 2021, according to an ASPA Report

Podcast: Will Viatris deal inject fresh momentum into Biocon biz?

Sohini Das caught up with Biocon Biologics CEO Shreehas Tambe to know more about the deal and the company's future plans

Sun Pharmaceuticals' Halol plant gets 'import alert' from USFDA

The USFDA had imposed an import ban on the Halol plant in December 2015 too

Pharma logs 17% growth in Nov; anti-infective therapy drives market demand

Key antibiotic brands like Augmentin (GSK) and Clavam (Alkem) clocked 25 per cent and 29 percent growth, respectively, in November, the data showed

Innovator drugs maintain market hold even after patent expiry, shows data

Merck's anti-diabetic molecule sitagliptin retains 81% market share in value terms

Local medical device makers seek trade margin rationalisation in Budget 23

Group wants basic custom duty on import of medical devices increased to 10-15%

Viatris deal gives Biocon Biologics entry in 100 countries: Shreehas Tambe

In a Q&A, the recently named MD & CEO of Biocon Biologics dwells on the scope for an IPO or stake sale to PE investors to retire the debt taken to fund the acquisition